You can use FDA device registration records by treating them as an official directory of establishment locations, registered activities, and listed devices, not as evidence that a product is cleared or approved. Owners or operators register annually under 21 CFR Part 807 and list the devices made at those locations [1]. The records therefore support supply-chain mapping, pre-inspection research, and competitor surveillance, but they contain no safety or performance conclusion [2]. A careful read of the regulation and FDA guidance shows that the public value comes from what is verifiable: who registered, where, when, and which devices they listed.
What the Registration Record Does and Does Not Prove
Every establishment owner or operator involved in production and distribution of medical devices for U.S. use must register annually with FDA [2]. The process is known as establishment registration under 21 CFR Part 807 [2]. The record associates an owner or operator number, a registration number, and any assigned listing numbers with a named place of business [8]. That is a useful anchor for identifying manufacturing sites and their declared scope of activity.
The same record cannot be read as a market authorization. FDA states that registration does not in any way indicate approval or clearance of establishments or products [3]. A registration number appearing in a database tells you that an owner or operator submitted information electronically, not that an inspector accepted the site or that a listed device cleared review. Regulatory analysts should still cross-reference premarket submission numbers where available, but absence from a search result is also not proof of noncompliance.
Building a Query from the Required Data Elements
The electronic device registration and listing system captures initial establishment registration information, updates to registration information, initial device listing information, and updates to device listing information, including updates reflecting discontinuance or resumption of commercial distribution [1]. If a device requires marketing authorization before being marketed in the U.S., the owner or operator should also provide the premarket submission number, such as a 510(k), De Novo, PMA, PDP, or HDE [2]. These fields are the backbone of a structured search: establishment name, owner or operator number, device listing number, and submission identifier.
A practical starting point is to pull all records associated with one owner or operator and then filter by the activities disclosed for each establishment [1]. Because registration and listing review occurs annually between October 1 and December 31, a record dated in that window reflects that the owner or operator was required to review the information and submit any necessary changes, not necessarily that no changes occurred [3]. Compare listings across cycles to detect newly added devices or sites that stopped reporting.
A Concrete Evaluation Example for a Device Family
Suppose a regulatory affairs analyst wants to identify every establishment associated with a particular infusion pump family. The analyst would start with the manufacturer's registration number and pull the device listing entries that reference the same premarket submission number [2]. Each listing links the device to a named establishment and its declared activity, such as manufacturing or initial importation [1].
The analyst would then compare that set with the firm's public statements about where the pump is made. A site absent from the listing set should be flagged for a direct inquiry to the CDRH Registration and Listing Help Desk at reglist@cdrh.fda.gov [2]. This suggested workflow does not prove a gap; it creates a focused question that the owner or operator must clarify.
Finally, the analyst would record the annual review date for each returned record and check whether any updates were filed outside the October 1 to December 31 window [3]. That date discipline matters because a listing confirmed in November reflects a different evidentiary status than one last updated years earlier.
Reading Discrepancies as Investigative Signals
Compliance program guidance directs investigators to review registration and listing as part of pre-inspection review for both domestic and foreign inspections, and to review a sample of device listings for accuracy during the inspection [4]. A discrepancy between a public listing and a firm's actual catalog can become an inspection discussion item [4]. Registrants face a tangible pressure point: if a manufacturer failed to register or has not registered accurately, or has not listed all devices or the listings are not accurate, this is discussed with management and documented in the EIR [4].
For an outside researcher, the same gap is a clue rather than a finding. A manufacturer may disclose one device family in registration records while marketing a related product elsewhere. That could reflect a delay, a data entry error, or a different establishment's responsibility. The registration record alone cannot resolve the question, but it identifies the specific owner or operator and location to examine further.
Where the Public Record Stops Being Useful
Some categories of establishment activity do not require a separate premarket submission, and some records are simply not captured in the public registration file. FDA may request additional device listing information, such as copies of labeling or advertisements, but that material is submitted by postal mail or email, not through the electronic system [1]. The public registration record therefore omits the labeling and promotional evidence that a detailed compliance review would need.
Registration also has a narrow deactivation logic. FDA recommends that a registration be deactivated if an establishment discontinues marketing and distributing its device [3]. A live record does not mean the site is actively shipping, and a deactivated record does not erase the historical listing. Researchers should preserve prior snapshots and note the as-of date, because the dataset is a moving administrative file rather than an audited registry.
Sources & references
- eCFR :: 21 CFR Part 807 -- Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices · www.ecfr.gov
- Device Registration and Listing | FDA · www.fda.gov
- Device Registration and Listing: An Introduction – Part 1 (FDA CDRH) · www.fda.gov
- Inspection of Medical Manufacturers - 7382.850 · www.fda.gov
- [PDF] Device Registration and Listing: An Introduction – Part 1 | FDA · www.fda.gov
- Content of Premarket Submissions for Device Software Functions · www.fda.gov
- Device Registration and Listing | FDA · www.fda.gov
- 21 CFR § 807.21 How to register establishments and list devices. · www.ecfr.gov